Adjuvant Herceptin regimens have become central to HER2-positive oncology protocols, driving robust demand for targeted monoclonal antibody therapies. Subcutaneous Herceptin formulations saw a 15% adoption increase in 2024 within hospital outpatient units, enhancing clinical efficiency. The Herceptin Market highlights evolving market dynamics, emerging market segments, and key market ... https://hallbook.com.br/blogs/721243/Global-Herceptin-Market-Trends-Expanding-Biosimilar-Approvals-and-Market-Dynamics